A citation-based method for searching scientific literature

Barbara M Norquist, Maria I Harrell, Mark F Brady, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Qian Yi, Robert A Burger, John K Chan, Susan A Davidson, Robert S Mannel, Paul A DiSilvestro, Heather A Lankes, Nilsa C Ramirez, Mary Claire King, Elizabeth M Swisher, Michael J Birrer. JAMA Oncol 2016
Times Cited: 331



Kelly L Bolton, Georgia Chenevix-Trench, Cindy Goh, Siegal Sadetzki, Susan J Ramus, Beth Y Karlan, Diether Lambrechts, Evelyn Despierre, Daniel Barrowdale, Lesley McGuffog, Sue Healey, Douglas F Easton, Olga Sinilnikova, Javier Benítez, María J García, Susan Neuhausen, Mitchell H Gail, Patricia Hartge, Susan Peock, Debra Frost, D Gareth Evans, Rosalind Eeles, Andrew K Godwin, Mary B Daly, Ava Kwong, Edmond S K Ma, Conxi Lázaro, Ignacio Blanco, Marco Montagna, Emma D'Andrea, Maria Ornella Nicoletto, Sharon E Johnatty, Susanne Krüger Kjær, Allan Jensen, Estrid Høgdall, Ellen L Goode, Brooke L Fridley, Jennifer T Loud, Mark H Greene, Phuong L Mai, Angela Chetrit, Flora Lubin, Galit Hirsh-Yechezkel, Gord Glendon, Irene L Andrulis, Amanda E Toland, Leigha Senter, Martin E Gore, Charlie Gourley, Caroline O Michie, Honglin Song, Jonathan Tyrer, Alice S Whittemore, Valerie McGuire, Weiva Sieh, Ulf Kristoffersson, Håkan Olsson, Åke Borg, Douglas A Levine, Linda Steele, Mary S Beattie, Salina Chan, Robert L Nussbaum, Kirsten B Moysich, Jenny Gross, Ilana Cass, Christine Walsh, Andrew J Li, Ronald Leuchter, Ora Gordon, Montserrat Garcia-Closas, Simon A Gayther, Stephen J Chanock, Antonis C Antoniou, Paul D P Pharoah. JAMA 2012
Times Cited: 357




List of shared articles



Times cited

Clinical impact of BRCA2 mRNA expression in high-grade serous ovarian cancer: validation using the TCGA cohort.
Irina Tsibulak, Verena Wieser, Hannah Welponer, Katharina Leitner, Hubert Hackl, Christian Marth, Heidelinde Fiegl, Alain G Zeimet. Acta Oncol 2021
0

Impact of BRCA1/2 Mutations on the Efficacy of Secondary Cytoreductive Surgery.
Felipe Leonardo Estati, Rafaela Pirolli, Viviane Teixeira Loiola de Alencar, Adriana Regina Gonçalves Ribeiro, Maria Nirvana Formiga, Giovana Tardin Torrezan, Dirce Maria Carraro, Andrea Paiva Gadelha Guimarães, Glauco Baiocchi, Alexandre André Balieiro Anastácio da Costa. Ann Surg Oncol 2021
3

Embedding a genetic counselor into oncology clinics improves testing rates and timeliness for women with ovarian cancer.
Huma Q Rana, Lindsay Kipnis, Kristin Hehir, Angel Cronin, Tim Jaung, Samantha M Stokes, Fatemeh Fekrmandi, Donna Vatnick, Ursula A Matulonis, Judy E Garber,[...]. Gynecol Oncol 2021
1

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Mary B Daly, Tuya Pal, Michael P Berry, Saundra S Buys, Patricia Dickson, Susan M Domchek, Ahmed Elkhanany, Susan Friedman, Michael Goggins, Mollie L Hutton,[...]. J Natl Compr Canc Netw 2021
13

CAMK2N1/RUNX3 methylation is an independent prognostic biomarker for progression-free and overall survival of platinum-sensitive epithelial ovarian cancer patients.
Karolin Heinze, Matthias Rengsberger, Mieczyslaw Gajda, Lars Jansen, Linea Osmers, Leticia Oliveira-Ferrer, Barbara Schmalfeldt, Matthias Dürst, Norman Häfner, Ingo B Runnebaum. Clin Epigenetics 2021
1

Plasma Protein Biomarkers Associated with Higher Ovarian Cancer Risk in BRCA1/2 Carriers.
Hee-Sung Ahn, Jung Yoon Ho, Jiyoung Yu, Jeonghun Yeom, Sanha Lee, Soo Young Hur, Yuyeon Jung, Kyunggon Kim, Youn Jin Choi. Cancers (Basel) 2021
0

Validation of BRCA testing on cytologic samples of high-grade serous carcinoma.
Si Kei Lou, Sylvie Grenier, Melanie Care, Jeanna McCuaig, Tracy L Stockley, Blaise Clarke, Heather M Ruff, Scott L Boerner. Cancer Cytopathol 2021
0

Exploring the Clinical Impact of Predictive Biomarkers in Serous Ovarian Carcinomas.
Cécile Le Page, Jacqueline Chung, Kurosh Rahimi, Martin Köbel, Diane Provencher, Anne-Marie Mes-Masson. Curr Drug Targets 2020
0

Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.
Panagiotis A Konstantinopoulos, Barbara Norquist, Christina Lacchetti, Deborah Armstrong, Rachel N Grisham, Paul J Goodfellow, Elise C Kohn, Douglas A Levine, Joyce F Liu, Karen H Lu,[...]. J Clin Oncol 2020
41

Genetic testing for epithelial ovarian cancer.
Noa Amin, Narda Chaabouni, Angela George. Best Pract Res Clin Obstet Gynaecol 2020
1

Germline and Somatic BRCA1/2 Mutations in 172 Chinese Women With Epithelial Ovarian Cancer.
Yan You, Lei Li, Junliang Lu, Huanwen Wu, Jing Wang, Jie Gao, Ming Wu, Zhiyong Liang. Front Oncol 2020
4

Emerging Treatments for Malignant Pleural Mesothelioma: Where Are We Heading?
Luca Cantini, Raffit Hassan, Daniel H Sterman, Joachim G J V Aerts. Front Oncol 2020
17



Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes.
Solene De Talhouet, Julien Peron, Aurelie Vuilleumier, Alex Friedlaender, Valeria Viassolo, Aurélie Ayme, Alexandre Bodmer, Isabelle Treilleux, Noemie Lang, Jean- Christophe Tille,[...]. Sci Rep 2020
11

BRCA immunohistochemistry for screening of BRCA mutation in epithelial ovarian cancer patients.
Tarinee Manchana, Patou Tantbirojn, Natkrita Pohthipornthawat. Gynecol Oncol Rep 2020
0

DNA Repair and Ovarian Carcinogenesis: Impact on Risk, Prognosis and Therapy Outcome.
Kristyna Tomasova, Andrea Cumova, Karolina Seborova, Josef Horak, Kamila Koucka, Ludmila Vodickova, Radka Vaclavikova, Pavel Vodicka. Cancers (Basel) 2020
6